Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1996 Oct;104(Suppl 5):879–882. doi: 10.1289/ehp.96104s5879

Protein adduct biomarkers: state of the art.

M J Meyer 1, W E Bechtold 1
PMCID: PMC1469716  PMID: 8933029

Abstract

Covalent protein adducts formed after exposure to xenobiotics may provide readily measurable indicators of these exposures. After adequate characterization of the dose-dependent formation of a specific adduct, the adduct can often be used as a quantitative marker for exposure, DNA adduct formation, or, possibly, risk of disease. By elucidating the structure of an adduct and studying the conditions under which it forms, information about the reactions that lead to its formation can be obtained. Continuing work in this area includes methods to expand the number, types, and levels of chemical exposures that can be studied by covalent adduct formation. In addition to the use of this technology in the field of occupational health, basic research in this area provides insights into metabolic pathways and biochemistry, as well.

Full text

PDF
880

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anwar W. A., Khalil M. M., Wild C. P. Micronuclei, chromosomal aberrations and aflatoxin-albumin adducts in experimental animals after exposure to aflatoxin B1. Mutat Res. 1994 Jul;322(1):61–67. doi: 10.1016/0165-1218(94)90033-7. [DOI] [PubMed] [Google Scholar]
  2. Autrup J. L., Schmidt J., Seremet T., Autrup H. Determination of exposure to aflatoxins among Danish workers in animal-feed production through the analysis of aflatoxin B1 adducts to serum albumin. Scand J Work Environ Health. 1991 Dec;17(6):436–440. doi: 10.5271/sjweh.1683. [DOI] [PubMed] [Google Scholar]
  3. Bailey E., Brooks A. G., Bird I., Farmer P. B., Street B. Monitoring exposure to 4,4'-methylenedianiline by the gas chromatography-mass spectrometry determination of adducts to hemoglobin. Anal Biochem. 1990 Nov 1;190(2):175–181. doi: 10.1016/0003-2697(90)90177-b. [DOI] [PubMed] [Google Scholar]
  4. Boogaard P. J., Fokkema G. N., Beulink G. D., Bouskill J., van Sittert N. J. Molecular dosimetry of 2,4-difluoroaniline in humans and rats by determination of hemoglobin adducts. Environ Health Perspect. 1994 Oct;102 (Suppl 6):27–29. doi: 10.1289/ehp.94102s627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bryant M. S., Simmons H. F., Harrell R. E., Hinson J. A. 2,6-Dimethylaniline--hemoglobin adducts from lidocaine in humans. Carcinogenesis. 1994 Oct;15(10):2287–2290. doi: 10.1093/carcin/15.10.2287. [DOI] [PubMed] [Google Scholar]
  6. Calleman C. J., Wu Y., He F., Tian G., Bergmark E., Zhang S., Deng H., Wang Y., Crofton K. M., Fennell T. Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol Appl Pharmacol. 1994 Jun;126(2):361–371. doi: 10.1006/taap.1994.1127. [DOI] [PubMed] [Google Scholar]
  7. Cheever K. L., DeBord D. G., Swearengin T. F., Booth-Jones A. D. ortho-toluidine blood protein adducts: HPLC analysis with fluorescence detection after a single dose in the adult male rat. Fundam Appl Toxicol. 1992 May;18(4):522–531. doi: 10.1016/0272-0590(92)90111-t. [DOI] [PubMed] [Google Scholar]
  8. Day B. W., Doxtader M. M., Rich R. H., Skipper P. L., Singh K., Dasari R. R., Tannenbaum S. R. Human serum albumin-benzo[a]pyrene anti-diol epoxide adduct structure elucidation by fluorescence line narrowing spectroscopy. Chem Res Toxicol. 1992 Jan-Feb;5(1):71–76. doi: 10.1021/tx00025a012. [DOI] [PubMed] [Google Scholar]
  9. Day B. W., Skipper P. L., Zaia J., Singh K., Tannenbaum S. R. Enantiospecificity of covalent adduct formation by benzo[a]pyrene anti-diol epoxide with human serum albumin. Chem Res Toxicol. 1994 Nov-Dec;7(6):829–835. doi: 10.1021/tx00042a017. [DOI] [PubMed] [Google Scholar]
  10. Ehrenberg L., Hiesche K. D., Osterman-Golkar S., Wenneberg I. Evaluation of genetic risks of alkylating agents: tissue doses in the mouse from air contaminated with ethylene oxide. Mutat Res. 1974 Aug;24(2):83–103. doi: 10.1016/0027-5107(74)90123-7. [DOI] [PubMed] [Google Scholar]
  11. Goergens H. W., Hallier E., Müller A., Bolt H. M. Macromolecular adducts in the use of methyl bromide as fumigant. Toxicol Lett. 1994 Jun;72(1-3):199–203. doi: 10.1016/0378-4274(94)90029-9. [DOI] [PubMed] [Google Scholar]
  12. Hammons G. J., Dooley K. L., Kadlubar F. F. 4-Aminobiphenyl-hemoglobin adduct formation as an index of in vivo N-oxidation by hepatic cytochrome P-450IA2. Chem Res Toxicol. 1991 Mar-Apr;4(2):144–147. doi: 10.1021/tx00020a003. [DOI] [PubMed] [Google Scholar]
  13. Lynch A. M., Murray S., Zhao K., Gooderham N. J., Boobis A. R., Davies D. S. Molecular dosimetry of the food-borne carcinogen MeIQx using adducts of serum albumin. Carcinogenesis. 1993 Feb;14(2):191–194. doi: 10.1093/carcin/14.2.191. [DOI] [PubMed] [Google Scholar]
  14. Meier J. R., Warshawsky D. Comparison of blood protein and target organ DNA and protein binding following topical application of benzo[a]pyrene and 7H-dibenzo[c,g]carbazole to mice. Carcinogenesis. 1994 Oct;15(10):2233–2240. doi: 10.1093/carcin/15.10.2233. [DOI] [PubMed] [Google Scholar]
  15. Osterman-Golkar S., Ehrenberg L., Segerbäck D., Hällström I. Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor. Mutat Res. 1976 Jan;34(1):1–10. doi: 10.1016/0027-5107(76)90256-6. [DOI] [PubMed] [Google Scholar]
  16. Shugart L. Quantifying adductive modification of hemoglobin from mice exposed to benzo[a]pyrene. Anal Biochem. 1986 Feb 1;152(2):365–369. doi: 10.1016/0003-2697(86)90421-5. [DOI] [PubMed] [Google Scholar]
  17. Umemoto A., Monden Y., Grivas S., Yamashita K., Sugimura T. Determination of human exposure to the dietary carcinogen 3-amino-1, 4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1) from hemoglobin adduct: the relationship to DNA adducts. Carcinogenesis. 1992 Jun;13(6):1025–1030. doi: 10.1093/carcin/13.6.1025. [DOI] [PubMed] [Google Scholar]
  18. Vineis P., Caporaso N., Tannenbaum S. R., Skipper P. L., Glogowski J., Bartsch H., Coda M., Talaska G., Kadlubar F. Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking. Cancer Res. 1990 May 15;50(10):3002–3004. [PubMed] [Google Scholar]
  19. Walker V. E., MacNeela J. P., Swenberg J. A., Turner M. J., Jr, Fennell T. R. Molecular dosimetry of ethylene oxide: formation and persistence of N-(2-hydroxyethyl)valine in hemoglobin following repeated exposures of rats and mice. Cancer Res. 1992 Aug 15;52(16):4320–4327. [PubMed] [Google Scholar]
  20. Weston A., Caporaso N. E., Taghizadeh K., Hoover R. N., Tannenbaum S. R., Skipper P. L., Resau J. H., Trump B. F., Harris C. C. Measurement of 4-aminobiphenyl-hemoglobin adducts in lung cancer cases and controls. Cancer Res. 1991 Oct 1;51(19):5219–5223. [PubMed] [Google Scholar]
  21. Wild C. P., Jiang Y. Z., Allen S. J., Jansen L. A., Hall A. J., Montesano R. Aflatoxin-albumin adducts in human sera from different regions of the world. Carcinogenesis. 1990 Dec;11(12):2271–2274. doi: 10.1093/carcin/11.12.2271. [DOI] [PubMed] [Google Scholar]
  22. Wild C. P., Jiang Y. Z., Sabbioni G., Chapot B., Montesano R. Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment. Cancer Res. 1990 Jan 15;50(2):245–251. [PubMed] [Google Scholar]
  23. Yu M. C., Skipper P. L., Taghizadeh K., Tannenbaum S. R., Chan K. K., Henderson B. E., Ross R. K. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Cancer Inst. 1994 May 4;86(9):712–716. doi: 10.1093/jnci/86.9.712. [DOI] [PubMed] [Google Scholar]
  24. Zwirner-Baier I., Neumann H. G. Biomonitoring of aromatic amines. IV: Use of hemoglobin adducts to demonstrate the bioavailability of cleavage products from diarylide azo pigments in vivo. Arch Toxicol. 1994;68(1):8–14. doi: 10.1007/s002040050024. [DOI] [PubMed] [Google Scholar]
  25. van Sittert N. J., Beulink G. D., van Vliet E. W., van der Waal H. Monitoring occupational exposure to ethylene oxide by the determination of hemoglobin adducts. Environ Health Perspect. 1993 Mar;99:217–220. doi: 10.1289/ehp.9399217. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES